Phase II Study of Neoadjuvant Gemcitabine, Pegylated Liposomal Doxorubicin, and Docetaxel in Locally Advanced Breast Cancer

An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for Human Epidermal Growth Factor Receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cancer.

Bonnefoi, H.
Zaman, K.
Debled, M.
Fiche, M.
Fournier, M.
Nobahar, M.
Pierga, J.Y.
Koch, K.M.
Bartlett, J.
Zimmer, A.
Marreaud, S.
Bogaerts, J.
Cameron, D.

January 2013

BACKGROUND: Lapatinib is an effective anti-HER2 therapy in advanced breast cancer and docetaxel is o...

Phase II open-label study of bevacizumab combined with neoadjuvant anthracycline and taxane therapy for locally advanced breast cancer

Clavarezza, M
Turazza, M
Aitini, E
Saracchini, S
Garrone, O
Durando, A
De Placido, S
Bisagni, G
Levaggi, A
Bighin, C
Restuccia, E
Scalamogna, R
Galli, A
Del Mastro, L

January 2013

Background: Neoadjuvant anthracycline- and taxane-based chemotherapy is frequently administered in b...

A. Alexopoulos
M. V. Karamouzis
H. Stavrinides
A. Ardavanis
J. Stavrakakis
C. Georganta
G. Rigatos

January 2004

Background: The aim of this study was to determine the activity and safety of pegylated liposomal do...

A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer

Xin Yao, Janet Hosenpud, Christopher R. Chitambar, John Charlson, Yee Chung Cheng

January 2012

Background: Neoadjuvant chemotherapy with concurrent docetaxel, doxorubicin and cyclophosphamide is ...

Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem)

McCarthy, N.
Boyle, F.
Gebski, V.
Veillard, A. S.
Zannino, D.
Wilcken, N.
Reaby, L.
Lindsay, D. F.
Badger, H. D.
Forbes, J. F.
Zdenkowski, N.
Bull, J.
Leong, E.
Simpson, A.
Kannourakis, G.
Francis, P. A.
Chirgwin, J.
Abdi, E.

January 2014

Background: Neoadjuvant chemotherapy has a sound rationale for use in women with large operable brea...

Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem)

McCarthy, N.
Boyle, F.
Zdenkowski, N.
Bull, J.
Leong, E.
Simpson, A.
Kannourakis, G.
Francis, P. A.
Chirgwin, J.
Abdi, E.
Gebski, V.
Veillard, A. S.
Zannino, D.
Wilcken, N.
Reaby, L.
Lindsay, D. F.
Badger, H. D.
Forbes, J. F.

April 2014

Background: Neoadjuvant chemotherapy has a sound rationale for use in women with large operable brea...

Phase II clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neoadjuvant treatment in stages II and IIIA HER2-overexpressing breast cancer patients. GEICAM 2003-03 study

Antón, A
Ruiz, A
Plazaola, A
Calvo Martínez, Lourdes
Seguí, M. A.
Santaballa, A.
Muñoz, M.
Sánchez, P.
Miguel, A.
Carrasco, E.
Lao, J.
Camps, J.
Alfaro, J.
Antolín, S.
Cámara, M. C.

January 2011

BACKGROUND: we previously reported a phase I trial of liposome-encapsulated doxorubicin citrate (LD...

Neoadjuvant pegylated liposomal doxorubicin in combination with cisplatin and infusional fluoruracil (CCF) with and without endocrine therapy in locally advanced primary or recurrent breast cancer

R. Torrisi
E. Montagna
E. Scarano
S. Dellapasqua
G. Cancello
M. Iorfida
A. Luini
P. Veronesi
G. Viale
A. Goldhirsch
M. Colleoni

January 2011

Purpose: To explore the activity of pegylated liposomal doxorubicin (PLD) as neoadjuvant therapy of ...

A Phase Ii Trial of Docetaxel, Capecitabine, and Cisplatin as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer

盧彥伸
Lu, Y. S.

October 2009

Background: docetaxel (T), capecitabine (X), and cisplatin ( P) are active chemotherapy for patients...

A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22

Trudeau, Maureen E
Chapman, Judith-Anne W
Guo, Baoqing
Clemons, Mark J
Dent, Rebecca A
Jong, Roberta A
Kahn, Harriette J
Pritchard, Kathleen I
Han, Lei
O’Brien, Patti
Shepherd, Lois E
Parissenti, Amadeo M

March 2018

Abstract This phase I/II neoadjuvant trial (ClinicalTrials.gov identifier NCT00066443)...

A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22

Trudeau, Maureen E
Chapman, Judith-Anne W
Guo, Baoqing
Clemons, Mark J
Dent, Rebecca A
Jong, Roberta A
Kahn, Harriette J
Pritchard, Kathleen I
Han, Lei
O’Brien, Patti
Shepherd, Lois E
Parissenti, Amadeo M

December 2015

Abstract This phase I/II neoadjuvant trial (ClinicalTrials.gov identifier NCT00066443)...

The Efficacy of Pegylated Liposomal Doxorubicin-Based Neoadjuvant Chemotherapy in Breast Cancer: A Retrospective Case-Control Study in Taiwan

Chih-Chiang Hung
Youngsen Yang
I-Chen Tsai
Chiann-yi Hsu
Chia-Hua Liu
Jie-Ru Yang

January 2020

Breast cancer is a global issue regarding women’s health, and high incident rates remain in the Taiw...

A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22

Trudeau, Maureen E
Chapman, Judith-Anne W
Guo, Baoqing
Clemons, Mark J
Dent, Rebecca A
Jong, Roberta A
Kahn, Harriette J
Pritchard, Kathleen I
Han, Lei
O’Brien, Patti
Shepherd, Lois E
Parissenti, Amadeo M

March 2018

Abstract This phase I/II neoadjuvant trial (ClinicalTrials.gov identifier NCT00066443)...

Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancer.

Vriens, B.E.
Aarts, M.J.
Vries, B. de
Gastel, S.M. van
Wals, J.
Smilde, T.J.
Warmerdam, L.J. van
Boer, M. de
Spronsen, D.J. van
Borm, G.F.
Tjan-Heijnen, V.C.
Stienen, J.J.C.
Hermens, R.P.M.G.
Wennekes, L.
Schans, S.A. van de
Dekker, H.M.
Blijlevens, N.M.A.
Maazen, R.W.M. van der
Adang, E.M.M.
Krieken, J.H.J.M. van
Ottevanger, P.B.
et al.

January 2013

Abstract BACKGROUND: This study was designed to determine whether delivering neo-adjuvant chemothera...

Combination of pegylated liposomal doxorubicin and docetaxel as neoadjuvant therapy for breast cancer with axillary lymph node metastasis

Li Wang
Yang Hong
Jie Ma
Meng Han
Shuo Zhang
Baoen Shan
Yunjiang Liu

August 2020

Objective To evaluate the efficacy and safety of the combination of pegylated liposomal doxorubicin ...

An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for Human Epidermal Growth Factor Receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cancer.

Bonnefoi, H.
Zaman, K.
Debled, M.
Fiche, M.
Fournier, M.
Nobahar, M.
Pierga, J.Y.
Koch, K.M.
Bartlett, J.
Zimmer, A.
Marreaud, S.
Bogaerts, J.
Cameron, D.

January 2013

BACKGROUND: Lapatinib is an effective anti-HER2 therapy in advanced breast cancer and docetaxel is o...

Phase II open-label study of bevacizumab combined with neoadjuvant anthracycline and taxane therapy for locally advanced breast cancer

Clavarezza, M
Turazza, M
Aitini, E
Saracchini, S
Garrone, O
Durando, A
De Placido, S
Bisagni, G
Levaggi, A
Bighin, C
Restuccia, E
Scalamogna, R
Galli, A
Del Mastro, L

January 2013

Background: Neoadjuvant anthracycline- and taxane-based chemotherapy is frequently administered in b...

A. Alexopoulos
M. V. Karamouzis
H. Stavrinides
A. Ardavanis
J. Stavrakakis
C. Georganta
G. Rigatos

January 2004

Background: The aim of this study was to determine the activity and safety of pegylated liposomal do...

A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer

Xin Yao, Janet Hosenpud, Christopher R. Chitambar, John Charlson, Yee Chung Cheng

January 2012

Background: Neoadjuvant chemotherapy with concurrent docetaxel, doxorubicin and cyclophosphamide is ...

Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem)

McCarthy, N.
Boyle, F.
Gebski, V.
Veillard, A. S.
Zannino, D.
Wilcken, N.
Reaby, L.
Lindsay, D. F.
Badger, H. D.
Forbes, J. F.
Zdenkowski, N.
Bull, J.
Leong, E.
Simpson, A.
Kannourakis, G.
Francis, P. A.
Chirgwin, J.
Abdi, E.

January 2014

Background: Neoadjuvant chemotherapy has a sound rationale for use in women with large operable brea...

Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem)

McCarthy, N.
Boyle, F.
Zdenkowski, N.
Bull, J.
Leong, E.
Simpson, A.
Kannourakis, G.
Francis, P. A.
Chirgwin, J.
Abdi, E.
Gebski, V.
Veillard, A. S.
Zannino, D.
Wilcken, N.
Reaby, L.
Lindsay, D. F.
Badger, H. D.
Forbes, J. F.

April 2014

Background: Neoadjuvant chemotherapy has a sound rationale for use in women with large operable brea...

Phase II clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neoadjuvant treatment in stages II and IIIA HER2-overexpressing breast cancer patients. GEICAM 2003-03 study

Antón, A
Ruiz, A
Plazaola, A
Calvo Martínez, Lourdes
Seguí, M. A.
Santaballa, A.
Muñoz, M.
Sánchez, P.
Miguel, A.
Carrasco, E.
Lao, J.
Camps, J.
Alfaro, J.
Antolín, S.
Cámara, M. C.

January 2011

BACKGROUND: we previously reported a phase I trial of liposome-encapsulated doxorubicin citrate (LD...

Neoadjuvant pegylated liposomal doxorubicin in combination with cisplatin and infusional fluoruracil (CCF) with and without endocrine therapy in locally advanced primary or recurrent breast cancer

R. Torrisi
E. Montagna
E. Scarano
S. Dellapasqua
G. Cancello
M. Iorfida
A. Luini
P. Veronesi
G. Viale
A. Goldhirsch
M. Colleoni

January 2011

Purpose: To explore the activity of pegylated liposomal doxorubicin (PLD) as neoadjuvant therapy of ...

A Phase Ii Trial of Docetaxel, Capecitabine, and Cisplatin as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer

盧彥伸
Lu, Y. S.

October 2009

Background: docetaxel (T), capecitabine (X), and cisplatin ( P) are active chemotherapy for patients...

A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22

Trudeau, Maureen E
Chapman, Judith-Anne W
Guo, Baoqing
Clemons, Mark J
Dent, Rebecca A
Jong, Roberta A
Kahn, Harriette J
Pritchard, Kathleen I
Han, Lei
O’Brien, Patti
Shepherd, Lois E
Parissenti, Amadeo M

March 2018

Abstract This phase I/II neoadjuvant trial (ClinicalTrials.gov identifier NCT00066443)...

A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22

Trudeau, Maureen E
Chapman, Judith-Anne W
Guo, Baoqing
Clemons, Mark J
Dent, Rebecca A
Jong, Roberta A
Kahn, Harriette J
Pritchard, Kathleen I
Han, Lei
O’Brien, Patti
Shepherd, Lois E
Parissenti, Amadeo M

December 2015

Abstract This phase I/II neoadjuvant trial (ClinicalTrials.gov identifier NCT00066443)...

The Efficacy of Pegylated Liposomal Doxorubicin-Based Neoadjuvant Chemotherapy in Breast Cancer: A Retrospective Case-Control Study in Taiwan

Chih-Chiang Hung
Youngsen Yang
I-Chen Tsai
Chiann-yi Hsu
Chia-Hua Liu
Jie-Ru Yang

January 2020

Breast cancer is a global issue regarding women’s health, and high incident rates remain in the Taiw...

A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22

Trudeau, Maureen E
Chapman, Judith-Anne W
Guo, Baoqing
Clemons, Mark J
Dent, Rebecca A
Jong, Roberta A
Kahn, Harriette J
Pritchard, Kathleen I
Han, Lei
O’Brien, Patti
Shepherd, Lois E
Parissenti, Amadeo M

March 2018

Abstract This phase I/II neoadjuvant trial (ClinicalTrials.gov identifier NCT00066443)...

Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancer.

Vriens, B.E.
Aarts, M.J.
Vries, B. de
Gastel, S.M. van
Wals, J.
Smilde, T.J.
Warmerdam, L.J. van
Boer, M. de
Spronsen, D.J. van
Borm, G.F.
Tjan-Heijnen, V.C.
Stienen, J.J.C.
Hermens, R.P.M.G.
Wennekes, L.
Schans, S.A. van de
Dekker, H.M.
Blijlevens, N.M.A.
Maazen, R.W.M. van der
Adang, E.M.M.
Krieken, J.H.J.M. van
Ottevanger, P.B.
et al.

January 2013

Abstract BACKGROUND: This study was designed to determine whether delivering neo-adjuvant chemothera...

Combination of pegylated liposomal doxorubicin and docetaxel as neoadjuvant therapy for breast cancer with axillary lymph node metastasis

Li Wang
Yang Hong
Jie Ma
Meng Han
Shuo Zhang
Baoen Shan
Yunjiang Liu

August 2020

Objective To evaluate the efficacy and safety of the combination of pegylated liposomal doxorubicin ...

An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for Human Epidermal Growth Factor Receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cancer.

Bonnefoi, H.
Zaman, K.
Debled, M.
Fiche, M.
Fournier, M.
Nobahar, M.
Pierga, J.Y.
Koch, K.M.
Bartlett, J.
Zimmer, A.
Marreaud, S.
Bogaerts, J.
Cameron, D.

January 2013

BACKGROUND: Lapatinib is an effective anti-HER2 therapy in advanced breast cancer and docetaxel is o...

Phase II open-label study of bevacizumab combined with neoadjuvant anthracycline and taxane therapy for locally advanced breast cancer

Clavarezza, M
Turazza, M
Aitini, E
Saracchini, S
Garrone, O
Durando, A
De Placido, S
Bisagni, G
Levaggi, A
Bighin, C
Restuccia, E
Scalamogna, R
Galli, A
Del Mastro, L

January 2013

Background: Neoadjuvant anthracycline- and taxane-based chemotherapy is frequently administered in b...

A. Alexopoulos
M. V. Karamouzis
H. Stavrinides
A. Ardavanis
J. Stavrakakis
C. Georganta
G. Rigatos

January 2004

Background: The aim of this study was to determine the activity and safety of pegylated liposomal do...

Phase II Study of Neoadjuvant Gemcitabine, Pegylated Liposomal Doxorubicin, and Docetaxel in Locally Advanced Breast Cancer

Abstract

Extracted data

Phase II Study of Neoadjuvant Gemcitabine, Pegylated Liposomal Doxorubicin, and Docetaxel in Locally Advanced Breast Cancer

Abstract

Extracted data

Related items

Related items